• Pfizer alumnus Geno Germano heads up nanoparticle startup Elucida fiercebiotech
    August 16, 2018
    When Geno Germano left Pfizer in 2016, he headed to the synthetic biology firm Intrexon, but left relatively quickly as a restructuring changed the startup’s focus. Now, the pharma veteran has taken the helm at Elucida Oncology
PharmaSources Customer Service